Global Medical Thawing System Market By Product Type (Manual and Automated), By Sample (Blood, Ovum, Embryo, Semen, and Others), End-Use (Hospitals, Blood Bank & Transfusion Centers, Tissue Banks, and Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Medical Thawing System Market Overview:

The market for medical thawing equipment was valued at USD 174.1 million in 2021. It is projected to grow at a 7.1% compounded annual growth rate (CAGR), from 2023-2032.

Global Medical Thawing System Market

Product Type Analysis

In 2021, manual thawing systems dominated the market, with a share of 57.1%. This is mainly due to their wide selection of products and high usage because of affordable prices. Because of its features, such as portability and ease of use, the automated thaw machine is expected to grow at a rapid pace.

The segment’s growth is also being driven by the increasing demand for a thawing system in point-of-care settings. Technological advancements and partnerships between major industry players are driving growth in the market for automated heating devices. Pluristem Therapeutics Inc., for the distribution of thawing products, signed a license agreement in December 2018.

Sample Analysis

A market share of 53.0% was held by the blood sample segment in 2021, which accounted for 53.0%. This dominance can be attributed to rising hemorrhage-related incidents and increasing demand for blood products.

The segment of embryos is expected to expand in the future. The embryo segment’s high growth rate can be attributed to the increase in live birth rate and pregnancy rate as a result. The demand for advanced thawing equipment is also increasing due to the growing adoption of IVF (in vitro fertilization) for infertility treatment.

According to the Centers for Disease Control and Prevention (CDC), there were more than 2.65 million attempts at in vitro fertilization in 2016. A variety of awareness campaigns are also increasing the number of embryo donor transfers. These factors are expected to boost the healthcare market for the forecast period.

End-Use Analysis

The market was dominated by the blood bank and transplant centers segment with a share of 31.3% in 2021. This dominance can be attributed to the high use of thawing equipment in these blood banks or transfusion centers. According to the World Health Organization (WHO), there are 13,300 blood centers worldwide that collect 106 million donations. Market growth is expected to be fueled by the increasing number of these institutions and donations.

The fastest expected CAGR for the tissue bank segment will be during the forecast period. Tissue banks are institutions that store human cadaver tissues and allow them to be used for research and education. Skin, tendons, bone joints, and cornea are the most common issues that can be stored. Many of these tissues are useful in the treatment of burn patients.

The success rate of tissue transplantation procedures can be increased by using advanced thawing technology. Market growth is expected to be driven by the increasing use of tissue products and technological advancements.

Key Market Segments

Product Type

• Manual
• Automated

Sample

• Blood
• Ovum
• Embryo
• Semen
• Others

End-use

• Hospitals
• Blood Bank & Transfusion Centers
• Biotechnology & Pharma
• Tissue Banks
• Others

Market Dynamics

Market growth is being driven by rising awareness, growing blood donors, and increased demand for advanced thawing methods. The market growth is also being driven by the growing demand for plasma on-demand thawing and technological advancements in thawing systems. Most trauma-related deaths result from hemorrhage.

The market is growing because of the increasing demand for thawed, frozen blood that can be quickly accessed for the treatment of major bleeding. Technology’s most advanced thaw system uses controlled temperature, agitation, and heat to reduce the time of thawing. This also helps ensure plasma safety and efficacy. You can choose from a range of sizes to best suit your needs, such as two bags, four bags, or eight bags.

Advanced thawing systems enable rapid thawing and maintain tissue quality. Additionally, the system’s space-saving design, LED digital thermometer, visual heater status indicator, audiovisual high-temperature alarm, and LED digital display make it more reliable. The demand for fast thawing of fresh frozen Plasma at the point-of-care, operating room, procedure area, at the patient’s bedside, or at the trauma site is expected to drive the market growth in the future.

The market’s growth has been aided by the increasing number of product launches and the speedy approval by the Food and Drug Administration (FDA). Oregon Scientific was granted FDA approval in February 2020 for its Zip Sleeve system and Zip Thaw system.

It’s next-generation, safe, lightweight, simple to use, dry, and requires virtually no maintenance. This growth can also be attributed to rising awareness about plasma donation and government initiatives to boost plasma donations.

Regional Analysis

North America held a dominant market share of 47.4% in 2021, and it is expected that it will continue to dominate in the future. The market is divided regionally into North America (Asia Pacific, Latin America, Europe, and the Middle East and Africa). High adoption rates, growing incidence of chronic conditions, as well as the presence of market leaders are some of the key factors that will drive North America’s market during the forecast period.

The Asia Pacific will likely experience the fastest rate of growth during the forecast period. It is comprised of developing countries, including India, China, and Japan. These countries have a large patient base with a high rate of chronic disease.

Thawed blood will be in demand due to an increase in the incidence of chronic diseases that can lead to organ dysfunctions. These countries are developing new technologies and offering many advanced surgical treatment options through booming healthcare tourism. Patients are attracted to the region by its relatively low cost of treatment. These factors are expected to fuel the Asia Pacific region’s growth.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share Analysis

The top players in this industry include Helmer Scientific USA, BioCision LLC, Boekel Scientific USA, Cardinal Health, Barkey, and Sartorius Germany. These companies have a large product portfolio and continue to innovate. These companies offer products for blood banks, hospitals, and tissue centers.

The market is growing due to the increased number of product launches, and the speedy FDA approval. BioCision LLC released two thaw units for 1.5 mL cryogenic vials and 6mL AY closed Vials in January 2016.

These companies are working to develop advanced thawing devices that can be used in different cell therapies. Technology advancements are expected to increase due to increased awareness about cell therapies and the high demand for specialized systems for different cell types. These advanced thaw systems are rapidly being adopted by the medical industry for general research as well as incorporation into in-process clinical trials and manufacturing.

Key Market Players

These are some of the major players in the global medical-thawing market:

• Helmer Scientific Inc.
• BioCision LLC
• SARSTEDT AG & Co. KG
• Boekel Scientific
• GE Healthcare
• Cardinal Health
• Barkey
• GE Healthcare
• Other Key Players

For the Medical Thawing System Market research study, the following years have been considered to estimate the market size: